Terms: = Liver cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
33 results:
1. Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis.
Tian S; Hu Y; Zhang M; Wang K; Guo G; Li B; Shang Y; Han Y
Arthritis Res Ther; 2023 Oct; 25(1):186. PubMed ID: 37784152
[TBL] [Abstract] [Full Text] [Related]
2. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
[TBL] [Abstract] [Full Text] [Related]
3. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
Sohn W; Kang D; Kang M; Guallar E; Cho J; Paik YH
Clin Mol Hepatol; 2022 Oct; 28(4):851-863. PubMed ID: 36263667
[TBL] [Abstract] [Full Text] [Related]
4. Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
Karam E; Tabutin M; Mastier C; Crignis L; Peyrat P; Martin V; Badon F; Muller X; Meeus P; Rivoire M; Dupré A
J Surg Oncol; 2023 Jan; 127(1):183-191. PubMed ID: 36169242
[TBL] [Abstract] [Full Text] [Related]
5. ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis.
Jiang K; Chen H; Ding K
Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
[TBL] [Abstract] [Full Text] [Related]
6. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
Xue JS; Liu H; Meng GX; Ding ZN; Yan LJ; Yao SY; Li HC; Dong ZR; Chen ZQ; Hong JG; Li T
Cancer Immunol Immunother; 2022 Jul; 71(7):1633-1644. PubMed ID: 34750662
[TBL] [Abstract] [Full Text] [Related]
8. Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway.
Zhou XQ; Mao XM; Fan R; Li SY; Shang J; Zhang T; Li RH; Li HQ; Hui Y; Chen WH; Wang ZX; Shen DY
Phytother Res; 2021 Oct; 35(10):5741-5753. PubMed ID: 34355433
[TBL] [Abstract] [Full Text] [Related]
9. treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma.
Han S; Choi HJ; Beom SH; Kim HR; Lee H; Lee JS; Lee HW; Park JY; Kim SU; Kim DY; Ahn SH; Han KH; Seong J; Won JY; Kim BK
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3123-3133. PubMed ID: 33893539
[TBL] [Abstract] [Full Text] [Related]
10. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-bmpr1a deletion.
Taylor H; Yerlioglu D; Phen C; Ballauff A; Nedelkopoulou N; Spier I; Loverdos I; Busoni VB; Heise J; Dale P; de Meij T; Sweet K; Cohen MC; Fox VL; Mas E; Aretz S; Eng C; Buderus S; Thomson M; Rojas I; Uhlig HH
Hum Mol Genet; 2021 Jun; 30(14):1273-1282. PubMed ID: 33822054
[TBL] [Abstract] [Full Text] [Related]
11. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
[TBL] [Abstract] [Full Text] [Related]
12. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with liver Imaging Reporting and Data System version 2017.
Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a long non‑coding RNA‑mediated competitive endogenous RNA network in hepatocellular carcinoma.
He H; Chen D; Cui S; Piao H; Tang H; Wang X; Ye P; Jin S
Oncol Rep; 2019 Aug; 42(2):745-752. PubMed ID: 31173261
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B.
Loglio A; Iavarone M; Grossi G; Viganò M; Rumi MG; Facchetti F; Lunghi G; Sangiovanni A; Colombo M; Lampertico P
Aliment Pharmacol Ther; 2018 Aug; 48(4):431-439. PubMed ID: 29920698
[TBL] [Abstract] [Full Text] [Related]
16. Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.
Yalniz FF; Murad MH; Lee SJ; Pavletic SZ; Khera N; Shah ND; Hashmi SK
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1920-1927. PubMed ID: 29550629
[TBL] [Abstract] [Full Text] [Related]
17. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract] [Full Text] [Related]
18. Operative Results and Oncologic Outcomes of Associating liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal liver Metastases: A Systematic Review and Meta-Analysis.
Moris D; Ronnekleiv-Kelly S; Kostakis ID; Tsilimigras DI; Beal EW; Papalampros A; Dimitroulis D; Felekouras E; Pawlik TM
World J Surg; 2018 Mar; 42(3):806-815. PubMed ID: 28798996
[TBL] [Abstract] [Full Text] [Related]
19. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
[TBL] [Abstract] [Full Text] [Related]
20. Solitary Large Hepatocellular Carcinoma: Staging and treatment Strategy.
Liu PH; Su CW; Hsu CY; Hsia CY; Lee YH; Huang YH; Lee RC; Lin HC; Huo TI
PLoS One; 2016; 11(5):e0155588. PubMed ID: 27176037
[TBL] [Abstract] [Full Text] [Related]
[Next]
